Cazanat 40 Cabozantinib Tablets I.P. 40 mg

Description

Cazanat 40 Tablets contain Cabozantinib I.P. 40 mg, a targeted anticancer medicine used in the treatment of advanced kidney, liver, and thyroid cancers. It works by inhibiting specific tyrosine kinases involved in tumor growth, blood vessel formation, and cancer spread. This medicine is taken orally, usually on an empty stomach, as prescribed by an oncologist. Cazanat helps slow disease progression and improve treatment outcomes. It should be used under strict medical supervision due to possible side effects.